Reductions in individual work productivity associated with type 2 diabetes mellitus

被引:62
作者
Lavigne, JE
Phelps, CE
Mushlin, A
Lednar, WM
机构
[1] Univ Rochester, Sch Med, Dept Community & Prevent Med, Rochester, NY 14642 USA
[2] Cornell Univ, Weill Med Coll, New York, NY USA
[3] Eastman Kodak Co, Rochester, NY USA
关键词
D O I
10.2165/00019053-200321150-00006
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: Chronic diseases and their treatments may cause symptoms that impair performance but are too mild to affect outcome measures such as absences and workforce exit. Objective: To assess the effect of type 2 diabetes mellitus on individuals' productivity when working, absences from work and the value of any lost work time. Methods: Subjects were identified from claims data and enrolled over the phone. A telephone survey was used to elicit information about productivity at work, absences, diabetes history, comorbidities, job characteristics, employment history, demographics and healthcare utilisation. The sample consisted of 472 employed residents of New York state, USA, of whom, 445 worked at one major US corporation. Of the 472 participants, 78 had type 2 diabetes. All participants agreed to release their claims data for this study; participants with diabetes also consented to the release of clinical records. All data were linked at the individual level. Tobit regression was used to model work efficiency losses, the total productivity time lost and the value of that time. Absences were modelled using Poisson regression. Productivity was measured using absences from work and work efficiency. Work efficiency was assessed using the Osterhaus model. Main outcome measures and results: Using the Osterhaus model of work productivity, type 2 diabetes was associated with a reduction in productivity at work. These productivity losses increased with the length of exposure to diabetes. Surprisingly, higher productivity losses among employees with diabetes did not translate into significantly higher productivity costs because the group with diabetes earned less. This likely reflects the prevalence of diabetes in populations. Among salaried people, very few reported working extra hours to make up for reduced productivity. Self-report biases may have been a factor in this finding. Type 2 diabetes was not associated with more frequent absences. Other factors that have strong effects on work efficiency are depression and colds, and job satisfaction. Conclusions: People with type 2 diabetes appear to experience incremental decrements in work performance that may affect their current and future health and performance. Lower incomes of participants with diabetes suggest that both people with diabetes and their employers bear the cost of any work efficiency losses.
引用
收藏
页码:1123 / 1134
页数:12
相关论文
共 12 条
[1]  
American Diabetes Association, 1992, DIR IND COSTS DIAB U
[2]   Workplace performance effects from chronic depression and its treatment [J].
Berndt, ER ;
Finkelstein, SN ;
Greenberg, PE ;
Howland, RH ;
Keith, A ;
Rush, AJ ;
Russell, J ;
Keller, MB .
JOURNAL OF HEALTH ECONOMICS, 1998, 17 (05) :511-535
[3]   GLUCOSE COUNTERREGULATION AND ITS IMPACT ON DIABETES-MELLITUS [J].
GERICH, JE .
DIABETES, 1988, 37 (12) :1608-1617
[4]   The cost to health plans of poor glycemic control [J].
Gilmer, TP ;
OConnor, PJ ;
Manning, WG ;
Rush, WA .
DIABETES CARE, 1997, 20 (12) :1847-1853
[5]  
KENNY SJ, 1995, DIABETES AM
[6]  
LAVIGNE JE, 2001, THESIS U ROCHESTER R
[7]   DEPRESSED SUBJECTS UNWITTINGLY OVERREPORT POOR SOCIAL-ADJUSTMENT WHICH THEY REAPPRAISE WHEN RECOVERED [J].
MORGADO, A ;
SMITH, M ;
LECRUBIER, Y ;
WIDLOCHER, D .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1991, 179 (10) :614-619
[8]   COSTS OF TEMPORARY AND PERMANENT DISABILITY INDUCED BY DIABETES [J].
OLIVERA, EM ;
DUHALDE, EP ;
GAGLIARDINO, JJ .
DIABETES CARE, 1991, 14 (07) :593-596
[9]  
Osterhaus J T, 1992, Pharmacoeconomics, V2, P67, DOI 10.2165/00019053-199202010-00008
[10]   Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus - A randomized, controlled, double-blind trial [J].
Testa, MA ;
Simonson, DC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17) :1490-1496